Literature DB >> 18180115

Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men.

Chun Chao1, Lisa P Jacobson, Donald Tashkin, Otoniel Martínez-Maza, Michael D Roth, Joseph B Margolick, Joan S Chmiel, Charles Rinaldo, Zuo-Feng Zhang, Roger Detels.   

Abstract

The effects of recreational drugs on CD4 and CD8 T cells in humans are not well understood. We conducted a longitudinal analysis of men who have sex with men (MSM) enrolled in the Multicenter AIDS Cohort Study (MACS) to define associations between self-reported use of marijuana, cocaine, poppers and amphetamines, and CD4 and CD8 T cell parameters in both HIV-uninfected and HIV-infected MSM. For the HIV-infected MSM, we used clinical and laboratory data collected semiannually before 1996 to avoid potential effects of antiretroviral treatment. A regression model that allowed random intercepts and slopes as well as autoregressive covariance structure for within subject errors was used. Potential confounders adjusted for included length of follow-up, demographics, tobacco smoking, alcohol use, risky sexual behaviors, history of sexually transmitted infections, and antiviral therapy. We found no clinically meaningful associations between use of marijuana, cocaine, poppers, or amphetamines and CD4 and CD8 T cell counts, percentages, or rates of change in either HIV-uninfected or -infected men. The regression coefficients were of minimum magnitude despite some reaching statistical significance. No threshold effect was detected for frequent (at least weekly) or continuous substance use in the previous year. These results indicate that use of these substances does not adversely affect the numbers and percentages of circulating CD4 or CD8 T cells in either HIV-uninfected or -infected MSM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180115      PMCID: PMC2691391          DOI: 10.1016/j.drugalcdep.2007.11.010

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  33 in total

Review 1.  Acute and chronic effects of cocaine on the immune system and the possible link to AIDS.

Authors:  G C Baldwin; M D Roth; D P Tashkin
Journal:  J Neuroimmunol       Date:  1998-03-15       Impact factor: 3.478

2.  Does the covariance structure matter in longitudinal modelling for the prediction of future CD4 counts?

Authors:  J M Taylor; N Law
Journal:  Stat Med       Date:  1998-10-30       Impact factor: 2.373

3.  The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men's Health Study.

Authors:  M J Di Franco; H W Sheppard; D J Hunter; T D Tosteson; M S Ascher
Journal:  Ann Epidemiol       Date:  1996-07       Impact factor: 3.797

4.  Smoking and leucocyte-counts. Results of an epidemiological survey.

Authors:  F Corre; J Lellouch; D Schwartz
Journal:  Lancet       Date:  1971-09-18       Impact factor: 79.321

5.  Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men followed for up to 2 years.

Authors:  R Detels; P English; B R Visscher; L Jacobson; L A Kingsley; J S Chmiel; J P Dudley; L J Eldred; H M Ginzburg
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

6.  Amyl nitrite alters human in vitro immune function.

Authors:  E M Dax; W H Adler; J E Nagel; W R Lange; J H Jaffe
Journal:  Immunopharmacol Immunotoxicol       Date:  1991       Impact factor: 2.730

7.  Cocaine use and HIV disease progression among heterosexuals.

Authors:  E P Larrat; S Zierler; K Mayer
Journal:  Pharmacoepidemiol Drug Saf       Date:  1996-07       Impact factor: 2.890

8.  Human T lymphocyte subpopulation and NK cell alterations in persons exposed to cocaine.

Authors:  P Ruiz; T Cleary; M Nassiri; B Steele
Journal:  Clin Immunol Immunopathol       Date:  1994-03

Review 9.  In vivo effects of cocaine on immune cell function.

Authors:  T Pellegrino; B M Bayer
Journal:  J Neuroimmunol       Date:  1998-03-15       Impact factor: 3.478

10.  Effects of amphetamine on cell mediated immune response in mice.

Authors:  M J Núñez-Iglesias; C Castro-Bolaño; C Losada; M D Pereiro-Raposo; P Riveiro; P Sánchez-Sebio; J M Mayán-Santos; M Rey-Méndez; M Freire-Garabal
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

View more
  23 in total

Review 1.  Cannabinoid neuroimmune modulation of SIV disease.

Authors:  Patricia E Molina; Angela Amedee; Nicole J LeCapitaine; Jovanny Zabaleta; Mahesh Mohan; Peter Winsauer; Curtis Vande Stouwe
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-10       Impact factor: 4.147

2.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

3.  Total and differential white blood cell count in cannabis users: results from the cross-sectional National Health and Nutrition Examination Survey, 2005-2016.

Authors:  Omayma Alshaarawy
Journal:  J Cannabis Res       Date:  2019-07-09

4.  Prevalence and correlates of marijuana use among HIV-seropositive and seronegative men in the Multicenter AIDS Cohort Study (MACS), 1984-2013.

Authors:  Chukwuemeka N Okafor; Robert L Cook; Xinguang Chen; Pamela J Surkan; James T Becker; Steve Shoptaw; Eileen Martin; Michael W Plankey
Journal:  Am J Drug Alcohol Abuse       Date:  2016-11-03       Impact factor: 3.829

5.  Self-reported Cannabis Use and Changes in Body Mass Index, CD4 T-Cell Counts, and HIV-1 RNA Suppression in Treated Persons with HIV.

Authors:  James T Lee; Lauren A Saag; Aaron M Kipp; James Logan; Bryan E Shepherd; John R Koethe; Megan Turner; Sally Bebawy; Timothy R Sterling; Todd Hulgan
Journal:  AIDS Behav       Date:  2020-04

Review 6.  Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems.

Authors:  Christina C Marasco; Cody R Goodwin; Danny G Winder; Nicole L Schramm-Sapyta; John A McLean; John P Wikswo
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-05

7.  Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study.

Authors:  S Shoptaw; R Stall; J Bordon; U Kao; C Cox; X Li; D G Ostrow; M W Plankey
Journal:  Int J STD AIDS       Date:  2012-08       Impact factor: 1.359

8.  Cocaine enhances HIV-1-induced CD4(+) T-cell apoptosis: implications in disease progression in cocaine-abusing HIV-1 patients.

Authors:  Jui Pandhare; Amma B Addai; Chinmay K Mantri; Cynthia Hager; Rita M Smith; Louis Barnett; Fernando Villalta; Spyros A Kalams; Chandravanu Dash
Journal:  Am J Pathol       Date:  2014-01-31       Impact factor: 4.307

9.  Cocaine modulates HIV-1 integration in primary CD4+ T cells: implications in HIV-1 pathogenesis in drug-abusing patients.

Authors:  Amma B Addai; Jui Pandhare; Victor Paromov; Chinmay K Mantri; Siddharth Pratap; Chandravanu Dash
Journal:  J Leukoc Biol       Date:  2015-02-17       Impact factor: 4.962

Review 10.  Epigenetics, drugs of abuse, and the retroviral promoter.

Authors:  Jasmine Shirazi; Sonia Shah; Divya Sagar; Michael R Nonnemacher; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.